Drugs / Hypertonic Sodium Lactate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00966628 | May 2008 → Apr 2009 | dengue shock syndrome | Innogene Kalbiotech Pte. Ltd | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01654653 | Jul 2008 → Mar 2009 | coronary artery disorder | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypertonic Sodium Lactate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01654653 ↗ |
| Known as | HSL | “Hypertonic Sodium Lactate (HSL) administration during cardiac surgery shows a promising effect.” NCT01654653 ↗ |